Slovenian drug company Krka's profits up by 11 pct in first half (updated)

Krka dd Novo Mesto

05/07/2018 13:35

(Updates with details, quote)
    LJUBLJANA, July 5 (Reuters) - Slovenian generic drug
producer Krka  KRKG.LJ  reported an 11 percent rise in
first-half group net profit of 101.4 million euros($119
million), the company said in a statement on Thursday.
    Sales rose by 4 percent to 680.5 million euros, it said.
    "Sales rose in all regions. In Eastern Europe, which is
Krka's biggest sales region ... they increased by 2 percent,"
Krka said.
    It also said sales in southeastern Europe were up by 11
percent, with the biggest rise recorded in Serbia, Bosnia and
Croatia.
    Krka is Slovenia's largest listed company with a market
capitalisation of about 1.9 billion euros.
    ($1 = 0.8543 euros)

 (Reporting by Marja Novak; editing by Jason Neely and Jane
Merriman)
 ((Marja.Novak@thomsonreuters.com; +386-1-5058805, Reuters
Messaging: marja.novak.thomsonreuters.com@reuters.net))